241 related articles for article (PubMed ID: 30209067)
21. Clinicopathologic implications of Myb and Beta-catenin expression in adenoid cystic carcinoma.
Park S; Vora M; van Zante A; Humtsoe J; Kim HS; Yom S; Agarwal S; Ha P
J Otolaryngol Head Neck Surg; 2020 Jul; 49(1):48. PubMed ID: 32650834
[TBL] [Abstract][Full Text] [Related]
22. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.
West RB; Kong C; Clarke N; Gilks T; Lipsick JS; Cao H; Kwok S; Montgomery KD; Varma S; Le QT
Am J Surg Pathol; 2011 Jan; 35(1):92-9. PubMed ID: 21164292
[TBL] [Abstract][Full Text] [Related]
23. MYB RNA detection by in situ hybridisation has high sensitivity and specificity for the diagnosis of adenoid cystic carcinoma.
Tadi S; Cheung VK; Lee CS; Nguyen K; Luk PP; Low TH; Palme C; Clark J; Gupta R
Pathology; 2023 Jun; 55(4):456-465. PubMed ID: 37055331
[TBL] [Abstract][Full Text] [Related]
24. MYB-NFIB fusion transcript in adenoid cystic carcinoma: Current state of knowledge and future directions.
Wagner VP; Bingle CD; Bingle L
Crit Rev Oncol Hematol; 2022 Aug; 176():103745. PubMed ID: 35738530
[TBL] [Abstract][Full Text] [Related]
25. Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms.
Brill LB; Kanner WA; Fehr A; Andrén Y; Moskaluk CA; Löning T; Stenman G; Frierson HF
Mod Pathol; 2011 Sep; 24(9):1169-76. PubMed ID: 21572406
[TBL] [Abstract][Full Text] [Related]
26. CXCR4 antagonist inhibits perineural invasion of adenoid cystic carcinoma.
Jeong WJ; Choi IJ; Park MW; An SY; Jeon EH; Paik JH; Sung MW; Ahn SH
J Clin Pathol; 2014 Nov; 67(11):992-8. PubMed ID: 25118295
[TBL] [Abstract][Full Text] [Related]
27. Cell-type-specific tumour sensitivity identified with a bromodomain targeting PROTAC in adenoid cystic carcinoma.
Rose AJ; Fleming MM; Francis JC; Ning J; Patrikeev A; Chauhan R; Harrington KJ; Swain A
J Pathol; 2024 Jan; 262(1):37-49. PubMed ID: 37792636
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of MYB promoter methylation in salivary adenoid cystic carcinoma.
Shao C; Bai W; Junn JC; Uemura M; Hennessey PT; Zaboli D; Sidransky D; Califano JA; Ha PK
Oral Oncol; 2011 Apr; 47(4):251-5. PubMed ID: 21324728
[TBL] [Abstract][Full Text] [Related]
29. MYB RNA In Situ Hybridization Facilitates Sensitive and Specific Diagnosis of Adenoid Cystic Carcinoma Regardless of Translocation Status.
Rooper LM; Lombardo KA; Oliai BR; Ha PK; Bishop JA
Am J Surg Pathol; 2021 Apr; 45(4):488-497. PubMed ID: 33165092
[TBL] [Abstract][Full Text] [Related]
30. Increased retinoic acid signaling decreases lung metastasis in salivary adenoid cystic carcinoma by inhibiting the noncanonical Notch1 pathway.
Zhou MJ; Yang JJ; Ma TY; Feng GX; Wang XL; Wang LY; Ge YZ; Gao R; Liu HL; Shan L; Kong L; Chen XH
Exp Mol Med; 2023 Mar; 55(3):597-611. PubMed ID: 36879115
[TBL] [Abstract][Full Text] [Related]
31. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
Mitani Y; Liu B; Rao PH; Borra VJ; Zafereo M; Weber RS; Kies M; Lozano G; Futreal PA; Caulin C; El-Naggar AK
Clin Cancer Res; 2016 Feb; 22(3):725-33. PubMed ID: 26631609
[TBL] [Abstract][Full Text] [Related]
32. MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.
Rettig EM; Tan M; Ling S; Yonescu R; Bishop JA; Fakhry C; Ha PK
Laryngoscope; 2015 Sep; 125(9):E292-9. PubMed ID: 25963073
[TBL] [Abstract][Full Text] [Related]
33. A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma.
Ho AL; Dunn L; Sherman EJ; Fury MG; Baxi SS; Chandramohan R; Dogan S; Morris LG; Cullen GD; Haque S; Sima CS; Ni A; Antonescu CR; Katabi N; Pfister DG
Ann Oncol; 2016 Oct; 27(10):1902-8. PubMed ID: 27566443
[TBL] [Abstract][Full Text] [Related]
34. [Diagnostic value of MYB protein expression in adenoid cystic carcinoma and status of MYB gene copy number].
Huo Z; Zeng X; Wu S; Wu H; Meng Y; Liu Y; Luo Y; Cao J; Liang Z
Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):582-6. PubMed ID: 26705183
[TBL] [Abstract][Full Text] [Related]
35. Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model.
Younes MN; Park YW; Yazici YD; Gu M; Santillan AA; Nong X; Kim S; Jasser SA; El-Naggar AK; Myers JN
Mol Cancer Ther; 2006 Nov; 5(11):2696-705. PubMed ID: 17121916
[TBL] [Abstract][Full Text] [Related]
36. MYB Translocations in Both Myoepithelial and Ductoglandular Epithelial Cells in Adenoid Cystic Carcinoma: A Histopathologic and Genetic Reappraisal in Six Primary Cutaneous Cases.
Goto K; Kajimoto K; Sugino T; Nakatsuka SI; Yoshida M; Noto M; Kono M; Takai T
Am J Dermatopathol; 2021 Apr; 43(4):278-283. PubMed ID: 32732690
[TBL] [Abstract][Full Text] [Related]
37. MYB gene abnormalities t(6;9) in adenoid cystic carcinoma fine-needle aspiration biopsy using fluorescence in situ hybridization.
Hudson JB; Collins BT
Arch Pathol Lab Med; 2014 Mar; 138(3):403-9. PubMed ID: 24576033
[TBL] [Abstract][Full Text] [Related]
38. MYB alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signature.
Huang J; Fehr A; Jäwert F; Nilsson JA; Morris LGT; Stenman G; Andersson MK
Oral Oncol; 2024 Apr; 151():106763. PubMed ID: 38493544
[TBL] [Abstract][Full Text] [Related]
39. Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas).
Marchiò C; Weigelt B; Reis-Filho JS
J Clin Pathol; 2010 Mar; 63(3):220-8. PubMed ID: 20203221
[TBL] [Abstract][Full Text] [Related]
40. Adenoid cystic carcinoma: emerging role of translocations and gene fusions.
Wysocki PT; Izumchenko E; Meir J; Ha PK; Sidransky D; Brait M
Oncotarget; 2016 Oct; 7(40):66239-66254. PubMed ID: 27533466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
